| Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells K Namba, K Shien, Y Takahashi, H Torigoe, H Sato, T Yoshioka, ... Molecular Cancer Research 17 (2), 499-507, 2019 | 97 | 2019 |
| Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer H Sato, H Yamamoto, M Sakaguchi, K Shien, S Tomida, T Shien, H Ikeda, ... Cancer science 109 (10), 3183-3196, 2018 | 76 | 2018 |
| Antitumor activity of pan‐HER inhibitors in HER 2‐positive gastric cancer T Yoshioka, K Shien, K Namba, H Torigoe, H Sato, S Tomida, ... Cancer Science 109 (4), 1166-1176, 2018 | 48 | 2018 |
| Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer T Takeda, H Yamamoto, H Kanzaki, K Suzawa, T Yoshioka, S Tomida, ... PLoS One 12 (2), e0171356, 2017 | 48 | 2017 |
| Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells T Yoshioka, K Shien, T Takeda, Y Takahashi, E Kurihara, Y Ogoshi, ... Cancer science 110 (8), 2549-2557, 2019 | 40 | 2019 |
| Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis Y Takahashi, K Shien, S Tomida, S Oda, T Matsubara, H Sato, K Suzawa, ... Cancer Science 109 (11), 3634-3642, 2018 | 36 | 2018 |
| Anti‑tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations Y Ogoshi, K Shien, T Yoshioka, H Torigoe, H Sato, M Sakaguchi, ... Oncology Letters 17 (3), 2729-2736, 2019 | 28 | 2019 |
| Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations H Torigoe, K Shien, T Takeda, T Yoshioka, K Namba, H Sato, K Suzawa, ... Cancer science 109 (5), 1493-1502, 2018 | 26 | 2018 |
| Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma H Sato, M Sakaguchi, H Yamamoto, S Tomida, K Aoe, K Shien, ... Oncogenesis 7 (1), 11, 2018 | 17 | 2018 |
| Ganetespib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small cell lung cancer E Kurihara, K Shien, H Torigoe, T Takeda, Y Takahashi, Y Ogoshi, ... Anticancer research 39 (4), 1767-1775, 2019 | 12 | 2019 |
| Successful wound treatment using negative pressure wound therapy without primary closure in a patient undergoing highly contaminated abdominal surgery T Yoshioka, Y Kondo, T Fujiwara Surgical case reports 4 (1), 85, 2018 | 10 | 2018 |
| 小腸腸間膜嚢胞腺癌の 1 例 宇田征史， 吉岡貴裕， 伏見卓郎， 佐々木洸太， 松本朝子， 村田年弘， ... 日本臨床外科学会雑誌 74 (4), 968-972, 2013 | 9 | 2013 |
| 虫垂粘液嚢腫により生じた絞扼性イレウスの 1 例 吉岡貴裕， 公文剣斗， 村田年弘， 上塚大一， 宇田征史， 中井肇 日本臨床外科学会雑誌 76 (12), 3018-3022, 2015 | 8 | 2015 |
| Ultrastructural analysis of an enterolith composed of Deoxycholic acid M Iwamuro, Y Miyashima, T Yoshioka, T Murata, Y Miyabe, Y Kawai, ... Acta Medica Okayama 68 (6), 369-374, 2014 | 6 | 2014 |
| Efficacy of transperineal minimally invasive surgery with laparoscopic abdominoperineal excision for lower rectal cancer T Yoshioka, H Hasegawa, K Ikeda, K Teramura, Y Tsukada, Y Nishizawa, ... Surgery Today 53 (4), 490-498, 2023 | 5 | 2023 |
| Goblet cell carcinoid of the appendix: Six case reports T Toshima, R Inada, S Sakamoto, E Takeda, T Yoshioka, K Kumon, ... World Journal of Clinical Cases 12 (22), 5217, 2024 | 4 | 2024 |
| 嵌頓小腸が食道裂孔を経て縦隔内に嵌入した横行結腸間膜裂孔ヘルニアの 1 例 伏見卓郎， 吉岡貴裕， 松本朝子， 村田年弘， 上塚大一， 宇田征史 日本臨床外科学会雑誌 76 (11), 2831-2835, 2015 | 4 | 2015 |
| Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment … K Namba, S Tomida, T Matsubara, Y Takahashi, E Kurihara, Y Ogoshi, ... BMC cancer 19 (1), 175, 2019 | 3 | 2019 |
| A Case of Colonic Intussusception Caused by Cecal Lymphangioma and Requiring Emergency Surgery M Okuda, T Yoshioka, R Tsunemitsu, H Inoeu, R Inada, R Tsunemitsu Cureus 16 (6), 2024 | 1 | 2024 |
| Evaluating the clinical utility of universal screening to identify Lynch syndrome in stage III/III colorectal cancer patients: A prospective observational study in Japan. Y Yamamoto, Y Tsukada, T Kuwata, M Kojima, Y Hiraoka, H Taniguchi, ... Journal of Clinical Oncology 39 (3_suppl), 41-41, 2021 | 1 | 2021 |
